Stem-cell start-ups seek to crack the mass-production problem

Nature, Published online: 29 September 2021; doi:10.1038/d41586-021-02627-y

Commercial outfits are building the tools and know-how to manufacture treatments using induced pluripotent stem cells in the quantities required for clinical use.